Compare CSTL & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | TK |
|---|---|---|
| Founded | 2007 | 1973 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.3M | 937.1M |
| IPO Year | 2019 | 1995 |
| Metric | CSTL | TK |
|---|---|---|
| Price | $24.84 | $13.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $45.50 | N/A |
| AVG Volume (30 Days) | 253.5K | ★ 399.4K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 15.21% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $344,229,000.00 | N/A |
| Revenue This Year | $2.42 | N/A |
| Revenue Next Year | $12.69 | N/A |
| P/E Ratio | ★ N/A | $13.43 |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $14.59 | $7.12 |
| 52 Week High | $44.28 | $13.76 |
| Indicator | CSTL | TK |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 62.28 |
| Support Level | $24.89 | $12.09 |
| Resistance Level | $26.20 | $13.76 |
| Average True Range (ATR) | 0.95 | 0.44 |
| MACD | 0.21 | 0.05 |
| Stochastic Oscillator | 76.18 | 86.18 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.